Dna damage in myocardial cells of rats with experimental alcoholic cardiomyopathy: modifyng effects of fabomotizole and trimetazidene

Resume. Relevance. Alcoholic cardiomyopathy (ACM) is a specific heart muscle disease found in individuals with a history of long-term heavy alcohol consumption. Their underlying mechanisms are poorly known, leading to a lack of effective therapy. Related with oxidative stress DNA damage and cell death play an essential role in the development of alcoholic cardiomyopathy. The aim of present study - using previously developed translation model to evaluate the levels of DNA damage and apoptosis in the myocardium of rats with ACM and modulating effect of cardioprotective drugs. Methods. ACM was established by forced alcoholization of rats (10 % ethanol solution as the only source of drinking water for 24 weeks; mean daily ethanol consumption was 5.0-6.5 g/kg). Trimetazidine (20 or 30 mg/kg), fabomotizole (15 mg/kg) or their combination (20 + 15 mg/kg) were injected ip, daily during following 4 weeks of abstinence. DNA damage was evaluated using alkaline and neutral comet assay. Apoptosis was assessed by TUNEL assay in paraffin-embedded sections. Results. No DNA damage or apoptosis of the myocardial cells was observed in rats with alcoholic cardiomyopathy at the abstinence period. A decrease in the level of cardiomyocytes with a high degree of DNA fragmentation, referred to as “hedgehog” DNA comets and that are presumably cells at the stage of autophagic fragmentation of chromatin, was revealed. Treatment of rats at the abstinence period with cardioprotective drugs trimetazidine and fabomotizole or their combination raised “hedgehog” DNA comets level up to control value. Conclusion. Our findings allows considering the appearance of cardiomyocytes with highly fragmented DNA as an important mechanism for regulating and maintaining myocardial homeostasis in ACM.

алкогольная кардиомиопатия, ДНК-кометы, апоптоз, фабомотизол, триметазидин, alcoholic cardiomyopathy, DNA damage, comet assay, apoptosis, fabomotizole, trimetazidine

1. Ивашкин В.Т., Драпкина О.М., Ашихмин Я.И. Алкогольная кардиомиопатия // Медицинская помощь: Научно-практинеский журнал. - 2006. - №3. - С.11-15. [Ivashkin V.Т., Drapkina O.M., Yashikhmin Y.I. Alcoholic cardio-myopathy. Meditsinskaya pomoshch’: Nauchno-prakticheskii zhurnal. 2006;(3):11-15. (In Russ).]

2. Юсупова А.О. Алкогольная кардиомиопатия: основные аспекты эпидемиологии, патогенеза и лекарственной терапии // Рациональная фармакотерапия в кардиологии. - 2014. - Т. 10. - №6. - С:651- 658.

3. Крыжановский С.А, Цорин И.Б., Колик Л.Г., и др. Трансляционная модель алкогольной кардиомиопатии // Молекулярная медицина. - 2015. - №3. - С.40- 47

4. Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc. Toxicol. 2014;14(4):291- 308. DOI: 10.1007/s12012-014-9252-4

5. Дурнев А.Д., Жанатаев А.К., Шредер О.В., и др. Генотоксические поражения и болезни // Молекулярная медицина. - 2013. -№3. - С.3-19.

6. Цорин И.Б., Мирошкина И.А., Ионова Е.О., и др. Сравнительное изучение кардиопротекторного действия триметазидина и фабомотизола гидрохлорида у крыс со сформировавшейся алкогольной кардиомиопатией в условиях продолжающегося потребления этанола // Фармакокинетика и фармакодинамика. - 2016. - №3. -С.38-41.

7. Hartmann A., Agurell E., Beevers C., et al. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis. 2003;18(1):45-51.

8. Руководство по проведению доклинических исследований лекарственных средств. Ч.1. Методические рекомендации по оценке ДНК-повреждений методом щелочного гель-электрофореза отдельных клеток в фармакологических исследованиях. - М.: Гриф и К; 2012. - С.115-128. [Guidance on Preclinical Evaluation of Medicines. Part

9. Metodicheskie rekomendatsii po otsenke DNK-povrezhdenii metodom shchelochnogo gel’elektroforeza otdel’nykh kletok v farmakologicheskikh issledovaniyakh. Moscow: Grif i K.; 2012. P. 115-128. (In Russ).]

10. Сапожников А.Г., Доросевич А.Е. Гистологическая и микроскопическая техника: Руководство. - С.: САУ; 2000.

11. Жанатаев А.К., Анисина Е.А., Чайка З.В., и др. Феномен атипичных ДНК-комет // Цитология. - 2017. - Т.59. - №3. - С.163-168.

12. Lorenzo Y., Costa S., Collins AR, et al. The comet assay, DNA damage, DNA repair and cytotoxicity: hedgehogs are not always dead. Mutagenesis. 2013;28(4):427- 432. DOI: 10.1093/mutage/get018

13. Hartmann A., Kiskinis E., Fjollman A., et al. Influence of cytotoxicity and compound precipitation on test results in the alkaline comet assay. Mutat Res. 2001;(497):199- 212.

14. Akiyama K., Gluckman TL, Terhakopian A., et al. Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro. Tissue Cell. 1997;(29):733- 743.

15. Wang S., Ren J. Role of autophagy and regulatory mechanisms in alcoholic cardiomyopathy. Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2003-2009. DOI: 10.1016/j.bbadis.2018.03.016

16. Shimomura H., Terasaki F., Hayashi T., et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J. 2001;(65):965- 968. DOI: 10.1253/jcj.65.965

17. Saito T., Asai K., Sato S., et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy. 2016;12(3):579- 87. DOI: 10.1080/15548627.2016.1145326

18. Tu X., Wang C., Ru X., et al. Therapeutic effects of rapamycin on alcoholic cardiomyopathy. Exp Ther Med. 2017 Oct;14(4):2763- 2770. DOI: 10.3892/etm.2017.4901

19. Fujiwara Y., Wada K., Kabuta T. Lysosomal degradation of intracellular nucleic acids-multiple autophagic pathways. J. Biochem. 2017 Feb 1;161(2):145- 154. DOI: 10.1093/jb/mvw085